Compare DAN & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAN | INDV |
|---|---|---|
| Founded | 1904 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.4B |
| IPO Year | 2002 | 2014 |
| Metric | DAN | INDV |
|---|---|---|
| Price | $28.94 | $38.29 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $40.60 | N/A |
| AVG Volume (30 Days) | 1.4M | ★ 1.5M |
| Earning Date | 04-29-2026 | 06-08-2026 |
| Dividend Yield | ★ 1.34% | N/A |
| EPS Growth | 264.10 | ★ 8100.00 |
| EPS | ★ 9.89 | 0.69 |
| Revenue | ★ $7,500,000,000.00 | $1,239,000,000.00 |
| Revenue This Year | $1.89 | N/A |
| Revenue Next Year | $4.59 | N/A |
| P/E Ratio | ★ $2.93 | $54.91 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $15.31 | $13.45 |
| 52 Week High | $39.56 | $41.00 |
| Indicator | DAN | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 34.59 | 57.75 |
| Support Level | $28.30 | $35.36 |
| Resistance Level | $31.73 | $41.00 |
| Average True Range (ATR) | 1.85 | 1.30 |
| MACD | -0.76 | 0.04 |
| Stochastic Oscillator | 13.55 | 88.77 |
Dana Inc is provider of products to virtually every vehicle manufacturer in the world. Its technologies include drive systems (axles, driveshafts and transmissions); electrodynamic technologies (motors, inverters, software and control systems, battery-management systems, and fuel cell plates); sealing solutions (gaskets, seals, cam covers, and oil pan modules); thermal-management technologies (transmission and engine oil cooling, battery and electronics cooling, charge air cooling, and thermal-acoustical protective shielding); and digital solutions (active and passive system controls and descriptive and predictive analytics). The company has two operating segments: Light Vehicle and Commercial Vehicle. The Light Vehicles segment generates the majority of revenue.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).